PackTalk is a blog for the Healthcare Packaging Industry

COVID-19 and the Road to Recovery


Published on May 6, 2020

As COVID-19 continues to impact the world and remains a force against US MedTech firms, hold on. The pent-up demand for halted medical procedures is expected to be urgent. Yes, it remains complicated, but the medical device industry could face shortages as recovery begins.

As a global company, Oliver Healthcare Packaging (along with many others) has taken the wild ride of the COVID-19 crisis from the earliest weeks. First, our colleagues in China and Europe were impacted. Even as we knew the virus was coming to the US, our response had to be where we were in the moment. Still, those early emergencies helped inform the strategy for our US response, evoking an odd sort of gratitude.

Revenue, materials and mandatory on-site constraints remain daunting. Yet, as Daphne Allen speaks with MedTech business consultant Brian Chapman, the angst of zero visibility may be diminishing for those who can squint to see beyond the debris.

Areas of demand will include orthopedic, cardiac and all of the conditions dubbed non-emergency or elective. Areas of action include analyzing how we communicate with health care customers to ascertain how all of us can persevere to “be ready.” Let’s look to recovery, together!

Read Full MDDI Article


Comments (0)

Related Articles

COVID-19 Testing Supply and Capacity May Be Key to Reopening the Economy

May 29, 2020

Since the first confirmed COVID-19 case reported in the United States in late January, the nation has seen more than 1.6 million confirmed cases and approximately 96 thousand deaths. This number has risen higher than anticipated while states have been staying...

Learn More

Global Medical Device Regulations & Harmonization Efforts of Sterile Medical Pac...

May 29, 2020

We are going through a global health crisis which is unprecedented in our lifetime. This is a global pandemic which requires an international response. As such, it becomes even more important to understand global harmonization of best practices in the...

Learn More

The FDA Authorizes First COVID-19 Saliva-Based Test for Home

May 29, 2020

With COVID-19 test kits in high demand, the FDA has been authorizing new at-home sample collections to help make tests more accessible.

Until this point, all at-home tests have required collection from a patient’s nose using a nasal swab and saline. But,...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.